BMS is growing its clinical research program for gastro-enterology in Switzerland and around the world, with a commitment to advancing medical knowledge and improving patient outcomes. We are actively recruiting for multiple clinical trials. Additionally, we have outlined our areas of interest for supporting innovative research proposals. Our clinical trial team is readily available to address any inquiries you may have, and their contact information can be found at the bottom of this page.
Information on this webpage might contain BMS therapies without market authorization in Switzerland for the studied indication, patient population or combination therapy. Bristol Myers Squibb recommends not other uses of its products outside clinical trials than those outlined in the respective specific product information.
For more information, please contact our medical team or visit swissmedicinfo.ch
Clinical trial footprint
Want to learn about BMS’s global clinical trial footprint? Check out BMSScience.
Study Connect is the starting point for patients considering taking part in our clinical trials. It’s also a place for patients, their caregivers, and physicians to learn more about how clinical trials work and how they might be part of making sure new medicines are effective and safe.
Bristol Myers Squibb is seeking independent research applications across all indications. Within our Areas of Interest, we may outline specific criteria & therapeutic areas but may not include specific details. Concept applications submitted that best align with our interest will be considered & evaluated.
Our Competitive Research Grant process defines specific criteria that must be met for your application to be considered. The window for submission will close at a pre-defined time point. Concept applications that best align with our posted requirements will be considered, evaluated and compared against all other submissions during the open period prior to final determination of award
If you have any questions about gastroenterology clinical trials running in Switzerland, please contact our Clinical Trial Monitors: